Woong-Yang Park
Built the genome institute behind Samsung Medical Center's precision oncology programme and its single-cell studies of tumours.
Woong-Yang Park directs the Samsung Genome Institute, which runs clinical sequencing for the hospital and produces single-cell and spatial studies of lung, breast, and gastric tumours that underpin precision oncology trials there.
| Title | Journal | Year |
|---|---|---|
| Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma | Nature Communications | 2020 |
Pages like this
not linked directly; found by shared links- PersonNathan A. Pennell
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- CompanyValius Sciences
Shares Single-cell & spatial profiling, Comprehensive genomic profiling.
- PersonJeeyun Lee
Shares Samsung Medical Center, Comprehensive genomic profiling.
- PersonMiriam Merad
Shares Single-cell & spatial profiling, Non-small-cell lung cancer.
- PersonReinhard Büttner
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- PersonCharu Aggarwal
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- InstitutionKorean Cancer Study Group
Shares Samsung Medical Center, Comprehensive genomic profiling, Non-small-cell lung cancer.
- PersonTakashi Kohno
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.